The first aspartic acid of the DQxD motif for human UDP-glucuronosyltransferase 1A10 interacts with UDP-glucuronic acid during catalysis

被引:14
|
作者
Xiong, Yan [1 ]
Patana, Anne-Sisko [2 ]
Miley, Michael J. [4 ]
Zielinska, Agnieszka K. [1 ]
Bratton, Stacie M. [1 ]
Miller, Grover P. [1 ]
Goldman, Adrian [2 ,3 ]
Finel, Moshe [8 ]
Redinbo, Matt R. [5 ,6 ,7 ]
Radominska-Pandya, Anna [1 ]
机构
[1] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA
[2] Univ Helsinki, Inst Biotechnol, Helsinki, Finland
[3] Univ Helsinki, Ctr Neurosci, Helsinki, Finland
[4] Univ N Carolina, Dept Chem, Chapel Hill, NC USA
[5] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA
[6] Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA
[7] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[8] Univ Helsinki, Fac Pharm, Drug Discovery & Dev Technol Ctr, Helsinki, Finland
关键词
D O I
10.1124/dmd.107.016469
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
All UDP-glucuronosyltransferase enzymes (UGTs) share a common cofactor, UDP-glucuronic acid (UDP-GlcUA). The binding site for UDP-GlcUA is localized to the C-terminal domain of UGTs on the basis of amino acid sequence homology analysis and crystal structures of glycosyltransferases, including the C-terminal domain of human UGT2B7. We hypothesized that the (393)DQMD-NAK(399) region of human UGT1A10 interacts with the glucuronic acid moiety of UDP-GlcUA. Using site-directed mutagenesis and enzymatic analysis, we demonstrated that the D393A mutation abolished the glucuronidation activity of UGT1A10 toward all substrates. The effects of the alanine mutation at Q(394), D-396, and K-399 on glucuronidation activities were substrate-dependent. Previously, we examined the importance of these residues in UGT2B7. Although D-393 (D-398 in UGT2B7) is similarly critical for UDP-GlcUA binding in both enzymes, the effects of Q(394) (Q(399) in UGT2B7) to Ala mutation on activity were significant but different between UGT1A10 and UGT2B7. A model of the UDP-GlcUA binding site suggests that the contribution of other residues to cosubstrate binding may explain these differences between UGT1A10 and UGT2B7. We thus postulate that D-393 is critical for the binding of glucuronic acid and that proximal residues, e. g., Q(394) (Q(399) in UGT2B7), play a subtle role in cosubstrate binding in UGT1A10 and UGT2B7. Hence, this study provides important new information needed for the identification and understanding of the binding sites of UGTs, a major step forward in elucidating their molecular mechanism.
引用
收藏
页码:517 / 522
页数:6
相关论文
共 50 条
  • [41] Identification of the Human UDP-glucuronosyltransferase Isoforms Involved in the Glucuronidation of the Phytochemical Ferulic Acid
    Li, Xiaojun
    Shang, Liang
    Wu, Yaohua
    Abbas, Suzanne
    Li, Dong
    Netter, Patrick
    Ouzzine, Mohamed
    Wang, Hui
    Magdalou, Jacques
    DRUG METABOLISM AND PHARMACOKINETICS, 2011, 26 (04) : 341 - 350
  • [42] The human UDP glucuronosyltransferase, UGT1A10, glucuronidates mycophenolic acid
    Mojarrabi, B
    Mackenzie, PI
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 238 (03) : 775 - 778
  • [43] ISOLATION AND CHARACTERIZATION OF HYODEOXYCHOLIC-ACID - UDP-GLUCURONOSYLTRANSFERASE FROM HUMAN LIVER
    MATERN, H
    LAPPAS, N
    MATERN, S
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 200 (02): : 393 - 400
  • [44] Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liver
    Trottier, Jocelyn
    Verreault, Melaine
    Grepper, Susan
    Monte, Didier
    Belanger, Julie
    Kaeding, Jenny
    Garon, Patrick
    Inaba, Ted T.
    Barbier, Olivier
    HEPATOLOGY, 2006, 44 (05) : 1158 - 1170
  • [45] Molecular Docking-Based Design and Development of a Highly Selective Probe Substrate for UDP-glucuronosyltransferase 1A10
    Juvonen, Risto O.
    Rauhamaki, Sanna
    Kortet, Sami
    Niinivehmas, Sanna
    Troberg, Johanna
    Petsalo, Aleksanteri
    Huuskonen, Juhani
    Raunio, Hannu
    Finel, Moshe
    Pentikainen, olli T.
    MOLECULAR PHARMACEUTICS, 2018, 15 (03) : 923 - 933
  • [46] Selective oxidation of UDP-glucose to UDP-glucuronic acid using permeabilized Schizosaccharomyces pombe expressing human UDP-glucose 6-dehydrogenase
    Weyler, Christian
    Bureik, Matthias
    Heinzle, Elmar
    BIOTECHNOLOGY LETTERS, 2016, 38 (03) : 477 - 481
  • [47] Selective oxidation of UDP-glucose to UDP-glucuronic acid using permeabilized Schizosaccharomyces pombe expressing human UDP-glucose 6-dehydrogenase
    Christian Weyler
    Matthias Bureik
    Elmar Heinzle
    Biotechnology Letters, 2016, 38 : 477 - 481
  • [48] Comparative characterization of UDP-glucuronic acid (UDP-GlcUA) binding-site directed inhibitors with human UGT2B7 and 1A10.
    Bratton, Stacie Moseley
    Laakkonen, Liisa
    Patana, Anne-Sisko
    Mazur, Anna
    Miller, Grover P.
    Finel, Moshe
    Radominska-Pandya, Anna
    FASEB JOURNAL, 2009, 23
  • [49] Identification of UDP-glucuronosyltransferase 1A10 in non-malignant and malignant human breast tissues (vol 73, pg 611, 2008)
    Starlard-Davenport, Athena
    Lyn-Cook, Beverly
    Radominska-Pandya, Anna
    STEROIDS, 2009, 74 (06) : 548 - 549
  • [50] EVIDENCE THAT CARRIER-MEDIATED TRANSPORT OF UDP-GLUCURONIC ACID (UDPGLCUA) ACROSS THE ENDOPLASMIC-RETICULUM (ER) MEMBRANE IS RATE-LIMITING FOR GLUCURONIDATION BY UDP-GLUCURONOSYLTRANSFERASE (UGT) IN ENDOPLASMIC-RETICULUM VESICLES
    BOSSUYT, X
    BLANCKAERT, N
    GASTROENTEROLOGY, 1995, 108 (04) : A1038 - A1038